IFP Advisors
ACRS icon

IFP Advisors’s Aclaris Therapeutics ACRS Stock Holding History

IFP Advisors’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.21K Buy
+230
New +$1.31K ﹤0.01% 4428
2022
Q1 		– Sell
-5
Closed -$1K – 4540
2021
Q4 		$1K Buy
+5
New +$76 ﹤0.01% 2927
2021
Q1 		– Sell
-500
Closed -$9.8K – 2995
2020
Q4 		$3K Buy
+500
New +$2.11K ﹤0.01% 2477
2017
Q4 		– Sell
-12
Closed – – 3784
2017
Q3 		$0 Hold
12
– – ﹤0.01% 4053
2017
Q2 		$0 Buy
+12
New +$326 ﹤0.01% 4059

Other funds holding ACRS

Three Bridge Wealth Advisors
Three Bridge Wealth Advisors Los Altos, California $469M AUM 10.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

IFP Advisors's ACRS Position: Q3 2026 in Review

IFP Advisors opened a new position in Aclaris Therapeutics (ACRS) in Q3 2026: 230 shares worth $1.21K. The stake represents ﹤0.01% of the portfolio and ranks #4428 among its holdings. This is a return to the name: IFP Advisors previously reported a position in ACRS as recently as Q4 2021.

IFP Advisors first reported a position in ACRS in Q2 2017 and has held it in 5 quarters since. The position peaked at $3K in Q4 2020. 41 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.

  • IFP Advisors held 230 shares of Aclaris Therapeutics worth $1.21K as of Q3 2026.
  • Aclaris Therapeutics was a new IFP Advisors position in Q3 2026.
  • Aclaris Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4428 holding.
  • IFP Advisors first reported a position in Aclaris Therapeutics in Q2 2017 and has held it in 5 quarters since.
  • IFP Advisors's Aclaris Therapeutics position peaked at $3K in Q4 2020.
  • 41 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.